Prespecified secondary analysis of a trial in 98 patients having valve-in-valve TAVR for failed small surgical valves: self-expanding valves met intended performance more often than balloon-expandable at 3 years (82.4% vs 27.6%); clinical outcomes were similar.
Secondary analysisn = 98
Cepas-Guillén et al. Balloon- Versus Self-Expanding Transcatheter Valves for Failed Small Surgical Aortic Bioprostheses: 3-Year Results of the LYTEN Trial